Albert Beraldo
Fortune : 242 031 $ au 30/06/2026
Fortune : 242 031 $ au 30/06/2026
Albert George Beraldo was the founder of Alveda Pharmaceuticals, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2006 to 2015.
Current jobs include Chairman at Global Transplant Solutions, Inc. since 2018; Director at Medicenna Therapeutics, Inc.; Lead Independent Non-Executive Director at Medicenna Therapeutics Corp.
since 2016; and President at Idoman Ltd. since 2008.
Former jobs include President & Chief Executive Officer at Telesta Therapeutics, Inc.; President & Chief Executive Officer at Bioniche Pharma Group Ltd. from 2005 to 2006; Independent Non-Executive Director at Telesta Therapeutics, Inc. from 2012 to 2014; Director at Helix BioPharma Corp.
from 2016 to 2017; Independent Director at Pure Global Cannabis, Inc. from 2018 to 2020; and Controller at Vetrepharm Canada, Inc. Education includes undergraduate studies at the University of Windsor.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 880 113 ( 0,95% ) | 242 031 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur/Membre du Conseil | 22/11/2016 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of central nervous system and urological cancers | Directeur/Membre du Conseil | - |
Idoman Ltd. | President | 01/07/2008 |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Provides human organ preservation fluid solutions | Président | 01/07/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| PURE GLOBAL CANNABIS INC. | Directeur/Membre du Conseil | 01/05/2020 |
| HELIX BIOPHARMA CORP. | Directeur/Membre du Conseil | 14/07/2017 |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sells and distributes pharmaceuticals and medical devices | Fondateur | 01/11/2015 |
| TELESTA THERAPEUTICS INC | Directeur/Membre du Conseil | 01/02/2014 |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Manufactures sterile injectable and other related pharmaceutical products | President | 01/01/2006 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Telesta Therapeutics, Inc.
Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets | Health Technology |
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
University of Windsor
University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Manufactures sterile injectable and other related pharmaceutical products | Health Technology |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sells and distributes pharmaceuticals and medical devices | Retail Trade |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of central nervous system and urological cancers | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Idoman Ltd. | |
Pure Global Cannabis, Inc.
Pure Global Cannabis, Inc. Pharmaceuticals: OtherHealth Technology Produces and distributes medical cannabis products | Health Technology |
Vetrepharm Canada, Inc. | |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Provides human organ preservation fluid solutions | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national